Primobolan (Methenolone Enanthate 100mg) – 1181/1

COMPOSITION

The 1 ml Primobolan-depot ampoule contains: Methenolone (D.C.I.) enanthate 100mg in oily solution.
Driver vehicle: castor oil for injection, benzoate benzoate.

EFFECTS

After injection of a vial of Primobolan-Depot, the reduction of organic nitrogen elimination – expression of increased protein synthesis – persists for more than 14 days. If it produces an improvement in general condition, stimulates activity, increases appetite, and can also increase weight.

INDICATIONS

Diseases and conditions requiring increased protein anabolism to improve general condition, stimulate healing processes, prevent sequelae of catabolic processes such as: convalence, postoperative treatment, consecutive diseases, anemia status, radiotherapy and cytostatic therapy, breast cancer or advanced genital in women, osteoporosis, protein deficiency, and chronic liver disease.

IMPORTANT:

To open the ampoule you do not need sandpaper. It breaks through the side marked by a dot.

Dose:

Primobolan-Depot, like all oily solutions, should be administered intramuscularly only.
*Adults:
1 ampoule (100mg) i.m. every 2 weeks
Once the desired initial result is achieved, continue with 1 i.m. every 3-4 weeks.
In women a smaller dose is sufficient: 1/2 ampoule (50mg) of primobolan-depot i.m. every 2-3 weeks. This dose should not be passed. In advanced acute cases of protein defict the initial dose may be raised to achieve the desired effect more quickly, as well as cutting the recommended ranges, for example: 2 ampoules (200mg) of Primobolan-Depot i.m. For initial treatment, continuation, 1 ampoule (100mg) each week.
In prolonged treatments, the intervals extend to 2-4 weeks. In special indications, woman’s breast or genital carcinomas, prolonged treatment with 1 ampoule (100mg) every 1-2 weeks or 2 ampoules every 2-3 weeks
* Teenagers over 50kg (15-18 years old)
1/2 ampoule (50mg) of Primobolan-Depot i.m. every 2 weeks. In patients who have not reached adulthood, a 4-6 week break should be given after taking the anabolic for 4 weeks.

Contraindications:

Methenolone enanthate contains an androgenic action. Therefore Primobolan-Depot should not be administered during pregnancy as it may present a risk of virilization in female infants. Primobolan-Depot should also not be given to patients with prostate carcinoma, as this substance may aggravate the condition.
Hypercalcemia

Side effects:

At therapeutic doses Primobolan-Depot generally has no androgenic side effects. In isolated cases, may present manifestations of virilization in some pre-arranged patients. Primoblan-Depot has no estrogenic properties.

Observations:

When there is a visible sensitivity to androgenic stimuli, as happens mainly in women, and girls, in isolated cases may present during treatment, signs of virilization, acne, hirsutism in the face and legs, slight thickening of voice, rudeness, etc. – Treatment should be discontinued if these manifestations appear. If changes in the voice appear, if the treatment is required to continue, there is a possibility that the process may become irreversible. For these reasons, it is recommended to limit the use of anabolics in women in absolutely necessary cases.
In patients who have not reached adulthood, treatment should be performed at the indicated intervals to avoid manifestations of virilization and acceleration of bone maturity.
In men it is recommended to perform prostate examinations at regular intervals.
During prolonged treatment with hormonal substances, such as those containing Primobolan-Depot, very rarely hepatic changes have been observed which may lead to treatment discontinuation. For this reason it is necessary to inform the doctor when presenting unusual epigastric disorders that do not disappear alone in a short time.